Article Details
Retrieved on: 2021-04-12 05:00:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Regeneron said a phase three clinical trial of the drug reduced the risk of symptomatic infections in individuals by 81%.
Article found on: www.cnbc.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here